Home

COVID-19 (Coronavirus) Pandemic

Mushuau Innu First Nation (MIFN) COVID-19 Pandemic Management Team

Structure

Health Commission

Information Posters
Coronavirus Factsheet Caring for a Person with COVID-19

Taking Care Mental Health During a Pandemic

How To Use Hand Sanitizer

Accordion Content

Cover Your Cough

Accordion Content

Help Flatten The Curve

Know The Facts About Coronavirus (MOE)

Know The Facts About Coronavirus (ENG)

About Coronavirus (COVID-19) Disease (MOE)

About Coronavirus (COVID-19) Disease (ENG)

Help Reduce The Spread of COVID-19 (MOE)

Help Reduce The Spread of COVID-19 (ENG)

How To Wash Your Hands

COVID-19 Prevention

How To Self-Isolate

Guide For Caregivers

Psychosocial - Best Practices
Supporting Vulnerable Populations

Psychological Impacts of COVID-19

 

 

 

 

Working From Home During the COVID-19

 

 

 

Public Health Orders

www.gov.nl.ca/covid-19/alert-system/public-health-orders/

 

COVID-19 Self-Assessement

www.811healthline.ca/covid-19-self-assessment/

 

Government of Newfoundland & Labrador COVID-19

www.gov.nl.ca/covid-19/

Contact Information
Mushuau Innu Health Commission
Phone: 709 478 8871

Vaccination Clinics

Clinics
Natuashish Covid-19 Vaccine Clinic

A reminder that the Covid-19 vaccination clinic in Natuashish will begin on Tuesday, January 19.  The location has changed – it will now be at the NGG area of the health commission.  I urge anyone who is 18 or older to make an appointment with the Health Commission staff to help protect yourself and others.  Please callAnna Nui at 478-8891; Megan Ashini at 478-8754.  

There will be a Radio Show and Facebook live at 3:30pm TODAY FRIDAY, January 15 with Dr Piggott, Medical Officer of Health for Labrador Grenfell Health.

 

The Moderna vaccine is safe and effective.  It protects individuals against the effects of the virus.  In vaccine studies (where many people were monitored for at least two months) – no serious side effects after receiving this vaccine were discovered.  Side effects are similar to other vaccines – (sore arm, feeling tired, headache).

 Here are some things that will help the immunization clinic run smoother:

  1. Immunizations are by appointment only. Please callAnna Nui at 478-8891; Megan Ashini at 478-8754 for an appointment time.
  2. People have to be able to physically distance and not have large crowds at NNG. Please do not bring your children (under 18) to the immunization clinic. The vaccine cannot be given to people under the age of 18.
  3. BRING YOUR MCP NUMBER to the clinic.
  4. Please wear a mask to the clinic.
  5. You will be asked some questions to make sure you don’t have Covid- 19 symptoms before entering the clinic.  You will be asked to clean your hands before going into the clinic.
  6. The vaccine will be given 2 doses, 28 days apart.  The second dose will be offered the week of February 15.
  7. People who are pregnant and/or breastfeeding or if you have problems with your immune system should have a discussion with your health care provider for an individualized discussion on the risks and benefits of the vaccine.

Here is some other important information everyone should know.

  1. The schedule:

Tuesday, January 19 from 10 am to 7 pm

Wednesday, January 20 from 10 am to 7 pm

Thursday, January 21 from 10am to 7 pm

Friday, January 22 – morning only (We don’t know the exact time right now, it will be shared)

  1. The priority list of people to get their vaccine are:

Elders

Front line workers (including Community Safety Officers)

General Public over 18

  1. Elders who cannot leave their homes, will be immunized by nurses in their home with the help of a translator
  2. Community Safety Officers will be in charge of security at the clinic to make sure LGH public health recommendations are followed
Chief Nui Getting The Covid-19 Vaccination On January 19th

Kathleen Benuen, Director Of Innu Health Centre, Getting Covid-19 Vaccination

Vials Of Moderna Covid-19 Vaccine

Information
COVID 19 Moderna Vaccination After Care Sheet (ENG)

Moderna COVID-19 Vaccine After Care Sheet

After you receive the vaccine, you should:

  • Wait for at least 15 minutes either in the clinic or outside the clinic (such as in your vehicle).

  • Leave your mask on and remain at least 2 metres away from anyone not part of your household during wait time.

  • Inform a health care provider at the clinic if you feel unwell.

  • Not operate a vehicle or other form of transportation for at least 15 minutes after being vaccinated or if you are feeling unwell.

Vaccine side effects can develop in the day or two after receiving the vaccine and will go away on their own.

      • The most common side effect is pain and swelling at the injection site. A cool, damp cloth or wrapped ice pack may help relieve any discomfort.
      • Others may include tiredness, headache, muscle pain, nausea, vomiting, joint pain, chills or fever.
      • Enlarged lymph nodes (swollen glands in the underarm) that last for several days may also occur.
      • Acetaminophen or ibuprofen may help with pain or fever.

Serious side effects after receiving the vaccine are rare but can include:

      • Hives (bumps on the skin that are often very itchy)
      • Swelling of the face, tongue or throat
      • Difficulty breathing

Should you develop symptoms of an allergic reaction call 9-1-1.

Serious side effects after vaccination should be reported to your local public health department by calling: __________________

Things to remember:

  • Return for your second dose of the vaccine in 28 days. It is very important to receive the second dose for the vaccine to work well.

  • Continue to follow the recommendations of local public health officials to prevent spread of COVID-19, such as wearing a mask, staying at least 2 metres from others and limiting social contacts.

  • Do not receive any other vaccines until you have received both doses of the COVID-19 vaccines. You must wait 28 days after the second dose of COVID-19 vaccine before you can receive any other vaccines.

  • Bring your immunization record with you for the second dose and tell the person providing the second dose about any side effects you experienced after the first dose.

  • Keep this sheet or other immunization record in a safe place. You can also download the CANImmunize app to keep track of this and other vaccines.

IMMUNIZATION RECORD

Name of client:

Date of birth of client (month/day/year):

Health card number / First Nations Status Card Number:

Record for Moderna COVID-19 Vaccine

Dose #

Date

Month/day/year

Lot number

Site

Given by

Name and professional designation

1

    

2

    
COVID 19 Moderna Vaccination After Care Sheet (MOE)

Vaccine Information

Information
Covid-19 Vaccine Info (ENG)

COVID-19 Vaccine 

https://www.gov.nl.ca/covid-19/vaccine/ 

 

COVID-19 Immunization Plan for Newfoundland and Labrador 

The development and implementation of a safe and effective COVID-19 immunization program is a key component to Newfoundland and Labrador’s COVID-19 response. Through the immunization program,  the number of cases, hospitalizations, and deaths will be reduced, allowing Newfoundlanders and Labradorians to return to normal everyday life over time. However, the COVID-19 immunization program is the largest and most complex ever developed in this province and Canada. 

The ultimate goal of Newfoundland and Labrador’s COVID-19 immunization program is to immunize as many people as quickly as possible in an ethical and risk-stratified manner, while obtaining public confidence in the immunization program. 

 

The public needs to have accurate and consistent information about COVID-19 vaccines to support them in making vaccination decisions. Misinformation about COVID-19 has been spread widely across the Internet and social media throughout the pandemic, making it difficult for public health officials to effectively communicate accurate and reliable information to the public. The Government of Newfoundland and Labrador is a trusted source for information on COVID-19 vaccines in Newfoundland and Labrador. 

This website will be revised on a regular basis as more details become available about COVID-19 vaccines. Check back regularly for updates. 

 

Get the Facts 

The Pfizer-BioNTech COVID-19 vaccine was approved by Health Canada on December 9, 2020 and the Moderna COVID-19 vaccine was approved by Health Canada on December 23, 2020. For information on the vaccine, please see the Government of Canada’s website. 

 

How does the Pfizer-BioNTech and Moderna COVID-19 vaccine work? 

This vaccine tells your body’s cells to make “spike proteins.” The spike proteins are specific to the virus that causes COVID-19. Your immune system will respond to the spike proteins by making antibodies that will fight off infection. Your new antibodies will break down the spike proteins and get rid of them. These new antibodies will protect you from illness if you are exposed to the COVID-19 virus. The vaccine does not contain the virus and so it cannot give you COVID-19. 

 

The Pfizer-BioNTech and Moderna vaccine has been tested in large clinical trials to ensure it has met safety standards, and has been licensed and approved by Health Canada. 

 

How many doses of the vaccine are required? 

The Pfizer-BioNTech vaccine requires two doses of vaccine given 19-23 days apart and the Moderna vaccine requires two doses given one month apart.  After receiving the two doses it may take another week to attain maximum protection against COVID-19. 

 

What age groups are offered the vaccine? 

The Pfizer-BioNTech vaccine can be given to those 16 years of age and older and the Moderna vaccine can be given to those 18 years of age and older. Given the limited supply of vaccine in early 2021, certain age groups will be prioritized. To determine your eligibility, please see Priority Groups. 

 

What are the side effects of the vaccine? 

Like any medication or supplement (including vitamins), vaccines can cause side effects and reactions. 

After being vaccinated, it’s common to have mild and harmless side effects. These can last a few hours or days after vaccination. Common side effects include: 

Pfizer-BioNTech 

  • pain at injection site 
  • tiredness 
  • headache 
  • muscle pain 
  • chills 
  • joint pain 
  • fever 
  • enlarged lymph nodes 

 

Moderna Vaccine 

  • pain at injection site 
  • tiredness 
  • headache 
  • muscle ache and stiffness 
  • chills 
  • joint pain 
  • fever 
  • enlarged lymph nodes 
  • swelling or redness at the injection site 
  • nausea and/or vomiting 

If you experience any unusual side effects after receiving the vaccine it is important to contact your health care provider or local public health office. 

 

Who should not receive the vaccine? 

Women who are pregnant, breastfeeding or planning to become pregnant should consult with their health care provider. If you are immunocompromised, have an autoimmune disorder, a bleeding disorder, and/or use blood thinner medication, you should also consult with your health care provider before getting vaccinated. 

 

Pfizer-BioNTech Vaccine 

The Pfizer-BioNTech vaccine is contraindicated in individuals: 

If you have a fever, are sick with COVID-19 symptoms, or have received a vaccine in the past 14 days (including the flu shot), you need to delay your vaccination. Once your symptoms subside and it has been more than 14 days since your last vaccination, you can proceed with getting vaccinated. 

 

Moderna Vaccine 

The Moderna vaccine is contraindicated in individuals: 

Consideration should be given to postponing immunization in persons with severe febrile illness or severe acute infection. Persons with moderate or severe acute illness should be vaccinated as soon as the acute illness has improved. 

 

Priority Groups 

Vaccine doses for the whole population will not arrive at the same time. Vaccine supply is expected to be limited in the beginning of the COVID-19 immunization program. Therefore, a phased approach is required in administering vaccines, starting with those most at risk of exposure to COVID-19, those most likely to experience severe complications due to COVID-19 infection, and those essential to maintaining the provincial pandemic response. 

 

Phase One 

The first shipment of COVID-19 vaccines has arrived, and shipments will continue through 2020 to 2021. These will include vaccines from Pfizer-BioNTech, and Moderna. 

 

In keeping with recommendations from the National Advisory Committee on Immunization (NACI), the initial supply of COVID-19 vaccine in Newfoundland and Labrador will be prioritized for the following groups: 

  • Congregate living settings for seniors; 
  • Health care workers at high risk of exposure to COVID-19, and those who are directly involved in the pandemic response; 
  • Advanced age; and 
  • Adults in remote or isolated Indigenous communities. 

 

In Phase One, sequencing of the above groups will be dependent on logistics, including limitations on transportation, storage and handling requirements, and availability of vaccines. Every effort will be made to prioritize immunization for individuals in the priority groups, while preventing wastage. However, due to restrictive storage and handling requirements, there is a risk of dose wastage if excess doses remain after completing immunization in a particular setting. In the event that excess doses cannot be relocated, they may be provided to individuals in priority groups that will follow Phase One. 

Congregate living settings for seniors includes all residents, staff and essential visitors at long-term care, personal care homes, community care homes, and assisted living facilities. Essential visitors are those considered, by the care team, to be paramount to the resident’s physical care and mental well-being, including assistance with feeding, mobility, or personal care; communication assistance; and assistance with significant behavioural symptoms. 

 

Health care workers includes all staff in acute care, long-term care, personal care homes, and community including home care workers. In Phase One, immunization will be prioritized for health care workers currently identified in the highest risk settings and those essential for ongoing COVID-19 response. This includes staff in the following settings: 

  1. COVID-19 testing and assessments; 
  2. Emergency departments and labour and delivery rooms (case rooms); 
  3. COVID-19 immunization programs; 
  4. COVID-19 units; and 
  5. Critical care units. 

 

The sequencing of vaccination for health care workers may change as COVID-19 epidemiology and vaccine logistics in Newfoundland and Labrador evolve. 

Advanced age includes those ages 85 years and above. 

Remote and/or isolated Indigenous communities includes First Nations and Inuit communities in the province where infection could have disproportionate consequences due to limited health infrastructure and circumstances which make it challenging to practice physical distancing and other infection prevention and control measures. Remote describes a geographical area where a community is located over 350 kilometres from the nearest service centre having year-round road access in all weather conditions. Isolated means a geographical area that has scheduled flights and good telephone service, but is without year-round road access. Remote-isolated means a geographic area that has neither scheduled flights nor year-round access in all weather conditions, and minimal telephone and radio service. 

At this time, vaccines will only be administered to adults ages 16 and over for the Pfizer-BioNTech vaccine and adults ages 18 and over for the Moderna vaccine. Children and youth under the age of 16 will be eligible for immunization following additional international vaccine trials that demonstrate vaccine safety for that age group. 

 

RATIONALE 

In Newfoundland and Labrador, the biggest risks for severe COVID-19 outbreaks are in congregate living settings for seniors (long-term care, personal care homes, community care homes, and assisted living facilities), in hospital settings, and remote or isolated Indigenous communities with limited health infrastructure. 

 

While Newfoundland and Labrador has had a very limited number of cases in congregate living settings for seniors to date, we have seen across the country the impacts that outbreaks can have in these facilities, which can often result in mass fatalities. Furthermore, residents of these facilities are primarily of advanced age and often have conditions that put them at further risk of severe complications and death due to COVID-19. Residents, staff and essential visitors need to be prioritized in the initial supply of COVID-19 vaccines to prevent outbreaks and severe outcomes in these settings, and stress to the health system. 

 

Health care workers are prioritized in order to maintain workforce stability, preserve health care capacity, and limit spread of COVID-19 infection in health care settings. The staff prioritized for vaccination in the initial vaccine allocation are those who are most likely to come into contact with an individual infected with COVID-19 and transmit to high-risk individuals, or are essential to maintaining the provincial COVID-19 response, such as those administering COVID-19 testing and providing COVID-19 immunizations. Other health care workers will be prioritized as more vaccine supply becomes available. 

 

Remote or isolated Indigenous communities, which includes First Nations and Inuit communities, may not have access to sufficient health care infrastructure in the event of an outbreak of COVID-19. While the remoteness of some Indigenous communities may offer a certain degree of protection from transmission of the virus, socioeconomic conditions such as overcrowding and chronic health conditions mean that an outbreak could be overwhelming. Newfoundland and Labrador has had no cases in remote or isolated Indigenous communities to date, and it is necessary to maintain this trend. Decisions regarding immunization in Indigenous communities will be made in partnership with Indigenous leaders. 

 

Phase Two 

Additional priority groups will be identified for immunization once most of the individuals in the above groups have been immunized and additional vaccine supply becomes available. In keeping with recommendations from NACI, these could include: 

  • Health care workers not included in Phase One; 
  • Residents and staff of all other congregate living settings; and 
  • Essential workers. 

These categories will be further defined as more is known about potential COVID-19 vaccines that will be available in Phase Two, including the number of doses, number and timelines of vaccines available, and storage and handling requirements. 

 

Phase Three 

Once most individuals in high-risk priority groups have been immunized, the vaccine will be offered to the general public. It is anticipated that enough vaccines will be available to vaccinate everyone in Canada by fall 2021. 

 

Vaccine Administration 

Initially, the COVID-19 immunization program will be delivered primarily by public health nurses with support from occupational health nurses for immunization of health care workers. 

In the early stages of Phase One, priority health care workers and staff at congregate living settings for seniors will be immunized first until redistribution is permitted. Other priority groups will be offered the vaccine once logistics allow. 

Health care workers will be provided with information on how to get immunized through their regional health authority. 

 

Vaccine Safety 

The development of COVID-19 vaccines is progressing very quickly for several reasons, including: advances in science and technology; international collaboration among scientists, health professionals, researchers, industry and governments; and, increased dedicated funding. However, any vaccines used in Canada must be approved by Health Canada through its rigorous regulatory process. The same review process is applied to all vaccines. 

COVID-19 vaccines will only be used in Newfoundland and Labrador if they are approved by Health Canada, and the evidence shows that they are safe, effective, of good quality and demonstrates that the benefits of using it outweighs the risks. For more information on Health Canada’s review process for COVID-19 vaccines, please see the Government of Canada’s website. 

Vaccines are constantly monitored after they are approved for safety and effectiveness. Pharmaceutical companies, health care providers and Health Canada are involved in this monitoring process. Health Canada and the Public Health Agency of Canada will take action if there are any problems with a vaccine. Vaccines are monitored in this way for as long as they are in use. 

 

 

Frequently Asked Questions 

 

What COVID vaccines are currently available in Canada? 

At this time, there are two vaccines available for use in Canada. Health Canada authorized Pfizer-BioNTech’s COVID-19 vaccine on December 9, 2020 and the Moderna vaccine on December 23, 2020.  For more information on this vaccine, please visit the Government of Canada’s website. 

 

When will the COVID vaccine be available? 

The first shipment of vaccines arrived in December 2020. Vaccine supply will be limited in the first quarter of 2021 and will be reserved for those identified in Newfoundland and Labrador’s priority groups. More people will be eligible for vaccination as more vaccine becomes available throughout 2021. 

 

Where will COVID vaccines be available? 

Information on priority groups and locations to obtain vaccine will be updated as more details on vaccines become available. Please visit the COVID vaccine website for the most up to date information. 

 

Who will be able to get the COVID vaccine? 

Since vaccine supply will be limited in the beginning of 2021, the provincial government will be prioritizing who receives the vaccine first. It is expected that more vaccines will become available throughout 2021 and will be offered to all eligible candidates by summer 2021. Remember to follow the public health measures of physical distancing, mask wearing, hand washing, and staying at home if ill regardless of whether you have been vaccinated. 

 

Is the COVID vaccine safe? 

COVID-19 vaccines will only be used in Newfoundland and Labrador if they are approved by Health Canada, and the evidence shows that they are safe, effective, of good quality and demonstrates that the benefits of using it outweighs the risks. For more information on Health Canada’s review process for COVID-19 vaccines, please see the Government of Canada’s website. 

 

Will there be enough vaccine for everyone? 

It will take some time and supply will be limited in the beginning of 2021. Not everyone will be vaccinated right away, but vaccination will continue throughout the year as more vaccines become available. It is anticipated that there will be enough vaccine to offer to all eligible people by summer 2021. 

 

Will I be able to choose which vaccine I receive? 

Vaccine supply will be limited at the beginning of 2021, so this may limit opportunities to choose which vaccine you receive. Vaccination is encouraged, but not mandatory. You do not have to be vaccinated if you do not want to. 

 

When someone is vaccinated, do they still have to wear a mask? 

Yes, it takes time to build an immune response and since everyone will not be getting vaccinated at the same time, we need to continue to protect each other by wearing a mask, physical distancing, hand washing and staying at home when ill. 

 

When will public health measures be lifted? 

The lifting of public health measures will be evidence-based and will depend on factors such as vaccination rates, efficacy of COVID-19 vaccines and the epidemiology of the disease in our province, country and world-wide. Public health measures, such as wearing a mask, physical distancing, handwashing and staying at home while ill should be followed by everyone until Public Health advises otherwise. 

 

Covid-19 Vaccine Info (MOE)

http://www.gov.nl.ca/covid-19/vaccine/ 

 

COVID-19 akushuen kashapushtautunanua ute Newfoundland mak Labrador 

 

Kaushitakents mak eshaminuants tshetsghi minuminuants mak tshetshika ueish nashpents tshekuan shapushtautunantshe ne akushuen COVID-19 kanashaniateua ute Newfoundland mak Labrador. Shapushtauakentaue auentshi, etateshets kaueshets, etateshets tukatshuapish etats, mak etateshets nepets auentshi tshatshi tshumpuenu put patush put auentshi ute newfoundland mak Labrador tshe minu iniuets eshkuen nete assi niutaue. Muk ume kashapushautunaua covid-19 aushuen kuinapatakanua enkuen nen nass meshats etutakents tshekuan kie eanamenitakuash uteteshe kashtitaiaua kashtasinash mak Canada. 

 

Man uatutakents nass ne Newfoundland mak Labrador uatutak covid-19 aushuen kashapushtautunanua tshetshi nass meshteshapushtauakenets auentshi  etateshets emanuenamuets tshetshi shapushtakueshits. 

 

Auentshi nass tshekuimenapuetamuts kie tshekuimenauitamuakanuets nenu COVID-19 natukunu tshetshi senitas tshetentashumushuts uishapushtakueshitaue. Mishue tshekuan nassishuanu tshekuan essitakuash akushun ute assits mishiue. Nete tipatshumuen takun kashetshamakanish mak nete tipatshemuen mishinanikanish ueshimakanuets auentshi mishiue. Eku mishiue ntuashtukushuets mak ntunishkuesets anamenitamuts tshetshi kie uinuau nassishuets etenitas kie tshetshi uitamuats nenua mishiue auenua. Ute uin Newfoundland mak Labrador enkuen nass emanuats tepatshemuen tsheutanamen euinantusenitamene COVID-19 aueshun kie ne natukun. 

 

Uta tepatshemuen katakuenua mushenau tshakatanekenu tshetshi minu uitamakunek ne eshpents COVID-19 natukun. Mushenau tshenantusenitamek eshpents. 

   

Tshekashtanamen tapueuen 

Ne Pfizer-BioNtech COVID-19  natukun Tsheutshemau Canada eshaniunanets kanakatuapatak tapuetamupan tshetshi apatshitakenets nauenta Pishamusa 9,2020 etshishtanakenatshi kie Moderna COVID-19 natukun eapets Tsheutshamau Canada tapuetamupan tshetshi apatshitakenets nta nau Pishamusa 23,2020 etshishtanakenetshi, tsheuapatamen Canada tsheutshamau meshananeken. 

 

Tan tshetutatsheten Pfizer-BioNtech kie Moderna COVID-19 natukun kanashaniateua? 

Ne natukun minakune tshekatasemaken tshetshi takuash nte tshinats tamish nau tshekanashanakuen aueshun kenashanakuenua muk meuen aueshun muk tshekanutshikum nenu aueshuenu tshetshika aueshen. Tshinats nte takuen ne uatshinakuen tshekuan eapets tshetshika sasakuets aueshen. Ne tshekuan etakuash nte tshinats kuetaka nenua tshekanitautshimekea minakuene ueshkatshiu natukun tshetshi nepatat nenu aueshunu. Kie antshe natautshimakash ne natukun nete tshinats enkuen tsheuitshionakuen kie tshenakatuenamekuen tshetshika aueshen aueshun uinatankuene. Ne natukun metakuenta aueshun eku tshekatshitshiminakuen kie tshekatshitshikashtene aueshun. 

 

Ne Pfizer-BioNtech mak Moderna natukun kenashaniatekenua tshash tshi mishue kuetshitakenu tshetshi menuakue eku tshash nenu Tsheutshamau Canada tapuetum tshetshi apatshitakenets. 

 

Tanta tau tsheshapushtauakenets auentshi? 

Ne Pfizer-BioNtech natukun muk nishuau shapushtauakenu auen 19-23 tasishakaua peik kie minuats kuetek eku uin ne kuetek Moderna natukun nishuau eapets peik nishtam tshet tshipekupishumueatshe patush kuetek. Eku patush mishiue tshishapushtakuene minuats ente peiku mashtakea tshekashanuatai tshetshi patush atusemakash ne natukun uinatankuene aueshun. 

 

Tae tatupuneshits auentshi tsheshapushtauakenets? 

Ne Pfizer-BioNtech natukun kenashaniateua ashutash tatushuap (16) etatupuneshets kie etu tshesheniuets kie ne kuetek Moderna natukun kenashaniateua aneaneu tatushuap (18) etatupuneshets kie etu tshesheniuets tshekaminakenuets. Meshuka mishea etakuashi nanu anushu kuepenua 2021, muk auentshi tshekautanakenuets tsheminakenets peta. Uintuseniteme tshetshi shapushtakuen: tshetshi tapatamen meshananeken. 

 

Ma aushishkatsheu ne natukun? 

Muk eshanakuash natukun aueshishkatsheu, tshatshi put aushishkatsheu ume natukun katakuenua. 

 

Tshishapushtakuene, tshatshi put pesish mushitai tshekuan. Muk pesish tsheka mushitashen kie tshekatshineuesh mushitai tshishapushtakune. Ne put tshekatamashiuen: 

 

Pfizer-BioNtech  

  • Tshakaueshen eta kashapushtautunants 
  • Kenteshkushinaua tshekatemashiuen 
  • Tshekaushen tsheshtakuan 
  • Tshekaueshen tshemuashashemets 
  • Tshekashiatamashiuen 
  • Tshekaueshen tsheshkea 
  • Tshekatsheteumashiuen 
  • Tekuente tshekuan tshinats tamits mishiue nanekueteni tshatshi patshapenu auen. 

 

Ekune Moderna natukun  

  • Tshakaueshen  eta kashapushtautunants 
  • Kenteshkushinaua tshekatemashiuen 
  • Tshakaushen tsheshtekuan 
  • Tshakaushen tshemuasheshemets kie kentshitushinaua tshekentamashiuen 
  • Tshekashiketamashiuen 
  • Tshekaueshen tsheshkea 
  • Tshekatsheteumashiuen 
  • Takuente tshekuan tshinats tamits mishiue nanekueteni tshatshi patshapenu auen 
  • Tshatshi patshapenu tshekuan kie kamiaua tshanashanakuen eta shapushtakuene 
  • Tshatshi ushtamashiuen kie tshatshi pakupakumen 

 

Mushitane tshekuan tshishapushtakune tshenashtapa tsheuitamuet tunishkues. 

 

Auen tshekashapushtauakent? 

Nashkueuets kapuauiutshi, kanunaushutshi put kauipuautshi tshekui uitamueuets tunishkuesa. Auen etakuenatshi utakushun tshetshika utshinakuet natukunu, kie etakuenakue shtakushun tshetshi sesakuets aueshen, mak auen kuitshaushukuna nete tamits uinats put auen natukunu kaminakenua tshetshi menapuenets muiuk. Tsheuitamuek tunishkues nenua tetamekue ketakunuani patush tshetshi shapushtakunek. 

 

Pfizer-BioNtech Vaccine 

Ne Pfizer-BioNtech natukun kenashiniateua tshekatshitshiminakenu auen senamakentshe tsheaushishkakuet nenu tetashe: 

  • Tshetshiushtashkakuet muk eshanakuenets natukunu katshi shapushtauakent 
  • Kie ekatshipueshapuatak tshekuanu natukunu muk eshanakuenets nenu etashtents (Product Monograph Pfizer_BioNtech COVID-19 Vaccine) 

 

Tshetemashiune put kashtaname COVID-19 akushun temashiune, kie tshishapushtakune ne natukun kashapushtautunanua mishue katshinishamuashtakeats (neushap tasishakaua 14 ) mak tshishapushtakune kutatshakumenanua. Uishanuapatame tshetshi shapushtakuen. Katatame tshekuan tshi neushap tasishakatshe tshishapushtakune, eku patush minuats tsheshapushtkuen  

  

Moderna Natukun  

Ne Moderna  natukun kenashiniateua tshekatshitshiminakenu auen senamakentshe tsheaushishkakuet nenu tetashe: 

 

  • Kie ekatshipueshapuatak tshekuanu natukunu muk eshanakuenets nenu etashtents (Product Monograph Pfizer_BioNtech COVID-19 Vaccine) 

Tshekamametenenamakenu peta auen tshetutuakent tshetshi ashanuapamakenets put auentshi kameshteakushutshi. Auentshi kashuka put kameshteakushutshi tshenashtapa tshekashapushtauakenuets muk patush tshinakatakutaue utakushunuau. 

 

Auentshi nishtam tshetshi tapamakenets peta 

Natukun tekuashe tshekatshi peta meshaue takuen peakuau. Nishtam natukun petautakentshe tshekatshi shuka meshau pesish peta tsheka takuen nishtam nta shapushtautunantshe. Papekuau tshekatutakenu shapushtauakentaue innuts, nishtam peta auentshi etenemakenets tshekakashtenamuets nenu COVID-19 aushuenu kie entshe etenemakenets tsheaushishkakuets etu kashtanakaue akushunu, kie entshe katusets kantueutshi kaushenuani nenu COVID-19 kentaushenuani. 

 

Nishtam peik 

Nishtem petautakentshe COVID-19 natukun, kie mushenau tshekapetautakenu neshpesh nete 2020 kie 2021. Nenua kenishanuani natukuna tshekatekuea Pfizer-BioNtech mak Moderna kenashiniateuani. 

 

Entshe essishuets uinuau tshetutakenets Nationa Advisory Comminttee kenashiatakenutshi nenu shapushtautunanetshe mak eshpashants natukunu penetautakenets ute Newfoundland mak Labrador kie nenua tshetshitapamakenatshi nitsham auenua peta: 

  • Tshekamamunakenuets tshenuets; 
  • Katusets eapets (tunishkuesets mak kuetakets ketusets nete tukatshuapish entshe etenamakenets tshetshi kashtanas nenu COVID-19, kie entshe kemashtananukushutshi euauitshaushits. 
  • Eapets entshe kamishetupuneshutshi; mak 
  • Kie kueteks innuts nete innu assits 

Enta nishtam kenanua, nishtam peta tshekatshitapatekenua tshekuana, tshenasha petautakents, tante tsheshtakents, kie tan tshenashaminuants, kie esitakuash ne natukun. Mesheue tshekuan tshekatutakenu tshetshi nass minpenitakents shapushtauakentaue innuts put kueteks auentshi entsh ketautshi nishtam tshatapamakenets, tshetshika nanuitakents natukun. Muk tapue, ekatukuash nte tsheshtakents kie tshenashaminuants, tshatshi put passe nanuitakenu nashkapentshe mante ueish ente put. Eku nashkapents tshatshi put minakenuets entshe kueteks kaeshpeakenets. 

 

Tshekamamunakenuets etateshets mishiue tshenuets mak mamu auentshi kueteks, katusets mak entshe kaueshutshi mushenau nete ketautshi tshenua kakeuenamakenuani, mak nete auentshi kueteks kakeuenamakanutshi uitshuats, mak ente ketautshi kakeuenamakanutshi eapets, mak ente kuetaka kakeuenamakanutshi auentshi katshinitutashutshi. Mak entshe katshinitutashutshi kuauitshakenutshi ketanuani unauitshinakuets, mak ukamuauets kanuneuetshi utuasemashuaua, mak katshipapamuteuetshi, mak entshe kemashtauauitshiakenutshi, mak kauetuniuakenutshi, mak mishiue tshekuanu kenitutuakenutshi. 

 

Katusets nete tukutshuapish

kie mishiue ukatuseshimuaua nete kenakatuenamakenuani tshenua put auenua katshiashinuani, neuesh kanakatuenematunants mishuap, uitshuats nete auen kanakatuenamakent mak ente mishuap kanakatuenamakanets auentshi.nishtam enta, katusets nishtam tshekauinakenuts nete etusets meshants akushunu nete meshtaushananets. Entshe katusets: 

 

  1. COVID-19 kentusenamatunanua 
  2. Tukentshuapish, nete neshkueuets kemanashiutshi  
  3. Nete shenapushtautunants 
  4. Nete pemashamakenets COVID-19 kaueshets 
  5. Mak nete COVID-19 kamashtaueshets kapamashamakenets 

Ane katusets kauishapushtauakenutshi tshekashapenu put tante COVID-19 essi takuash ne natukun nete Newfoundland mak Labrador tshenashpents 

 

Eku nass katsheniutshi 

mak entshe 85 (ainaneu tatenu ketatupuneshutshi kie ettu   

Kepapekushuani innu/esimeu assina utenaua mak nenua Innu assina kie esimeu assina nete kaetakush shuka tshekuan tshetshi natuakenets auentshi shuka kie eanamash tshetshi nashtutakents mishiue tshekuan eshpents kie aueshun tshenashanakatuapatakents kie tshenakushtanutakents. Epapekuesi nasishuanu assin nete innu assin put katakuash nete uauiu nass 350 kms kenanua etakuash tukentshuap muk meshkeu napatshitakents. Eku nete kueshteshe innu assina eka takuash meshkeu muk kapaminasht eapatshakent muk kamatuetes emanuats eapatshitakents, muk metakuen meshkau utapan tshetshi nashpatamakash. Eku uin nass ekatakuash tshekuan tshetshi nashpent kapaminasht put utapan tshetshi nashpatamakash mak ekashuka menuasht eapets kamatuetes kie eka shuka menuats kanatutakents. 

 

Eku anushu, natukun tshekaminuanu tshekashapushtauakenutets antshe (16) ashutatatushuap ketatupuneshutshi kie nete ettu nenu Pfizer-BioNtech natukunu kenasheniatenua kie entshe kueteks aneaneu tatushuap 18 ketatupuneshutshi kie ettu nashpamish Moderna natukunu kenashiniatenua uinuau tshekashapushtauakenuets. Eku kueteks uassets 16 etatupuneshets kie ente nashuk tshekatukunu eshk uinuau tshikutshitakenatshe kuetakenu natukunu eshkuente muk. 

 

Eshanakuash tshekuan    

Eku, ute Newfoundland mak Labrador, mante kueshtukuash aueshun COVID-19  tshetshi nashpents nete mashetets tshenuets , ( tshenuets kaueuenemakanutshi, auentshi uitshuats kakeuenamakanutshi, kuetaka auentshi akakeuenamatunantshi), tukutshuapa, mak nete innu assits eka shuka takuashi tshekuana tshenashatuakenets auentshi. 

 

Eku anushu ute Newfoundland mak Labrador, eka shuka takuash  aueshun kie ekashuka mishetets tshenuets tshetshi kashtanas, essi uapatamau nete kueshteshe essi mitshetets tshenuets nepanakuets nenu aueshunu nete kakeuenamakenutshi, tante nete timaken mashetanants nenua mitsghuapa kemamashauani kakeuenamakanutshi tshenuets. Tante auentshi entsh keneuenamakenets tshenuets nass kamishetapueneshutshi kie tshash entsh uipets uitshaueshuets eku nenu kenashtanas eku entu meshtaushets kenashtanas nenu COVID-19 aueshunu. Nete etats  tyyq1`21vcvauentshi utasiuats, katusets tukentshuapish, mak entsh etasets nete innu assits put eka ushits ente enkuets nishtam tsheminakenets nenu COVID-19 natukunu tante enkuets nass meshtatusets netukunuets kaiaushentshi auenua nete tukentshuapish. 

 

Tuashtakushuts, tunishkuesets, mishiue tukutshuapish katusets enkuets nishtam tshemamatenenamakenets tshetshi minakenets nenu natukunu tshetshi min pempanitats nenu tukatshuapenu kie tshetshi minu atusets, kie tshetshi kashuka meshats akushunu neshpentshente. Entshe nishtam kuishapushtauakenutshi katusets tekuanatshe natukunu entshe kenatukueiutshi nenua auenua COVID-19 aueshuenu  

  

kekashtanamanuani tante metshama nenua tshekataueuts etantshi mushenau kie tshetshi eka etu ashuminuets kie tshetshi manepuenets uishamakentaue kie tshetshi minu atusets kie entshe keminueutshi keuauitshaushiutshi nenu shenapushtautunanets. Eapets entsh kuetakets tshekashapushtauakanuets katusets etu takuenetshe natukunu. 

 

Nete kuetaka keapashashuani utenaua, innu mak esimeu utenaua, tsheka tshi put shuka takuenua tshekuana tshenashanatuakanets auentshi uetitakutaue COVID-19 aueshunu. Eapets entsh kepapekushuani keapashashuani utenaua eat kepua katakuen eshk COIVID-19 aueshun, tekuashe mante tshishue tshekatshapenu put auentshi tshenapanakuets. Eshkuente metakuen nete kepapekushuani utenua nete Newfoundland mak Labrador ne COVID-19 aueshun anushu, tshekaui kuetshitaiai tshetshi katakuash nass. Mamu shapushtautunantshe tshekui uitshetesemakenuets innu utshimauts. 

 

Kuetekets auentshi katusets tshekauishamakenuets shapushtautunanetshe tshishapushtauakentaue entshe nishtam kuetakets katusets etu tekuenatshe natukunu. Entshe  kantashuets NACI kenashiniashutshi, aietsh entsh:   

  • ENTSHENTS KASHTETSHAMAKANUTSHI TUKUTSHUAPISH KATUSETS KUETEKETS; 
  • AUENTSHI NETE KUETEKETS KATATS NETE UTENAUATS KIE KATUSETS MAMU ENTA KATATS ETUSETS 
  • MAK ENTSHE NISHTAM MESHTANANUKUSHUTSHI KENASHTATUSEUTSHI NETE TUKUTSHUAPISH KATUSETS. 

Enkuen nenua etu tsheuauitakentshi patush etu natukun kuetek tekuashe. Etu shapushtautunantshe tatau shapushtauakentaue innuts, kie minakentaue enta tshishakuenu tsheshapshtauakenets, kie eapets tantenu tsheshtats natukunu takuenetshe. 

  

Eku nass mishiue entshe etenamakenets tsheaueshets tshishapushtauakentaue, eku patush kuetekets tshetshitamamakenets tshetshi shapushtauakenets. Tsheka nashpenu put nanu natukun tshetshi mishiue shapushtauakenets auentshi nashpesh ete 2021 tekuatshishe. 

 

Tshenaminuants natukun 

Natunishkuesets mak nenua kuetaka tunishkuesa tshekauauitshinakuets COVIC-19 shapushtautunanetshe nete tukatshuapisish. 

 

Nishtam peta, tunishkuesets mak entshe katuseshimaua nete katushkuats tshenua uinashtemuau tshekashapushtauakenuets patush kueshteshe tshentutets tashumakentuaue. Kuetakets eapets tshekashapushtauakenuets katusets uetishepeakentaue. 

 

Tshekaminakenuets entshe tunishkuesets tshenashapushtaushuts neua utshamuaua tshekauitamakuets. 

 

Tshetshi menuats natukun 

Tshe tshenipinanu eueshitakents  natukun, ene uishatshenapents, mamu etashkatakents, eapatshitakentshi tshekuana, kamasish kauauitshaushits kamashtanantusenitas tshekuanu kanantuapatas mishiue eshanakuenets natukunu, mishte tuashtakuashuets, kanantusenitashets mishiue tshekuanu, tsheutshamuets, mak eapets emashtapatshitakents shuneau. Muk, mishiue eshanakuash natukun ute patakatakents Canada, tshekaui uapatum peta Canada patush tshetshi uetanak kie patush tshetapuetak. Eapets nenua mishiue kueshtekentshi natukuna ute etakuashi tshash Canada. 

 

Muk COVID-19 natukun tshekapatshitakenu ute Newoundland mak Labrador tapuetashe Health Canada utshimau, kie tapuetekentshe tshetshi menuats, atusemakash, kie senitakentshe tshetshi uitshinuet tshetshishakutat nenu aueshunu. Etu uintusenitamekue ene eshanakuash COVID-19 natukun, nete tshentutek kie tsheuapatamek Tsheutshamau meshananekenish nenu WEBSITE. 

 

Mushenau natukuna nakatuapatakenua katshi tapuetakentaui tshetshi apatshitakentshi kie tshetshi menuakaue kie tshetshi uitshinakuets auentshi kaueshets. Entsh auentshi katauatshets, tuashtakushuts mak Health Canada Utshemau mamu nakatuapatamuts nenua natukuna mishiue etapatshitakenatshi mak eshapashtanakenatshi. Health Canada Utshimauets mak ente mishiue tukuentshuapa katapenitak ute Canada tsheka tutamuets tshekuanu kamanapuenetshe nenu natukunu. Ekuen Natukuna mishiue eshanakatuapatakentshi napatshitakentaui. 

  

Kuekuetshishemunantshi tshekuan. 

 

Tshekuen COVID tukuna nanua etakuashi ute Canada? 

Anushu uin, muk nishena natukuna etakuashi ute Canada, Heath Canada tapuetamupen nenu Pfizer-BioNtech  COVID-19 natukunu enta nau Pishamusa 9, 2020 etshishtanakenatshi mak nenu Moderna natukunu enta Pishamusa 23, 2020 etshishtanakenatshi. Etu uintusenitamekue, nete tshentutek tshetshitapatamek Government of Canada’s website Tsheutshamau mueshananeken. 

 

Tanta tsheminuants ne COVID natukun?  

Tepatshemuen tshekatakuen entshe tsheminakenets nishtam kie ente tshentautakent nishtam auentshi tsheminakenets patush senitakentshe tshesitakuash natukun tekuashe. Etu uintusenitamekue  COVID natukun tepatshumun takuen enta COVID vaccine website 

 

Auenu tsheminakent COVID natukunu? 

Eku esikashuka takuash natukun ute 2021, Newfoundland Tsheutshamau tshekasenameu uin auenua nishtam tsheminakenatshi. Muk nanu etu put tshekatakuen eshkuete natukun eshkue ekamesapents 2021 kie mishiue tshekaminakenuets auentshi nipenatshe put 2021. Kie tsheuinatutamek mushenau tsheuinakatuapatamek eshakuashtiants tshekuan aueshun ketakuenua, tshetshika peshuapamatunants put uaiu tshetshi nipuashtuets auen kie tshe akueunushun shtashtemiu, tsheshtapautan shtishina mushenau, kie tshetan nte tshitshuash aueshene eapets tshishapushtakuene. 

  

Menuau uen kake ne natukun? 

COVID -19 natukuna muk ute tshakapatshitakenua Health Canada tapuetashe, kie tshekui teshteu meshananeken tshetshi menuats, shutshimakash, kie tshetshi tusemakash apatshitakentshe. Etu uintusenitamekue nete tshentutek Health Canada esheuauitak nenu COVID-19 aueshunu. Nete tutek tsheuapatamek Government of Canada’s website 

 

Tsheka nashpeakenuetsha mesheue auentshi? 

Neushashish tsheka nutshiakenu tshekuan kie tshekatshi shuka meshau natukun nta 2021, tsheka meshaue tshekatshi shapushtauakenuets auentshi, muk mushenau tsheka shapushtauakenuets petapetautakentshe natukun nipishe. Tsheka nashpeakenuts tenamakenuets mesheue nipenatshe 2021 tante etu tshekatakuen nanu natukun. 

 

Patshianin senite tshek natukun tsheutanaman?  

Enta nishtam tekuashe natukun 2021, tshekatshi shuka meshau kie tshekatshitshi tepanamuakenuets auentshi tshenashuatanas nenu tshek natukunu tsheuetanas. Etu tshamanuau nau shapushtautatunantshe muk tshin tshekauisenite tshetshi uetanamen. Tsheka shapushtakushin kauishapushtakushine.  

 

Shapushtauakentshe auen, tshakakuaiama utashtamiu?  

Ehe, neushashish tshekatesemeken natukun patush tshetshi mesheue nespents nte kie tshekatshi mesheue auentshi tshishapushtauakenuets tshenashtapa peikuau, eku tshekaui nakatuenamushunai kie tshekui nakatuenamaiats shtuasamenuets kie tshianashanuets ekuen tsheuitshakamutaiak ne katshapuaputakanua metun mak metashtamiu, mak uaiu kunakapushtatunanua, mak keshtapautakenuani metishina, kie kakueshtanakenutshi auentshi tshetshi anamutets naushataui. 

 

Tanta tshe punapents ane mesheue tshekuan kakushtianua?  

Patush nukuashe menapuents tshekuan mesheue metanu kie kashanuapatekenu tshetshi menuakue eshpents uishkatshiu keshapushtautunanua eapets. Tshenashpanakue COVID-19 natukun kie tshenashanakuenakue eshkuente ne aueshun katakuenua anuts ute kashtitaiaua kie nete kueshteshe assits mesheue eshpitashkamashkats assin. Eku eshk eapets nenua tshekatakuea kakueshtianuani tshekuana, kakueushunanua, uaiu kenipushtatunanua, kashtapaushtishanua, kie kakushatnakenua auen tshetshika anamutet naueshatshi. Patush tunishkueu menuau nessishuetshe. 

Video Message

Video from Dr. Thomas Piggott, Medical Officer of Health, Labrador-Grenfell Health

Watch Video Click Here

 

Natuashish Labrador Grenfell Health​ Regional Clinic

Contact Information

Labrador Grenfell Health

Contact Information

Toll Free
Tel: 855-897-2267
Client Relations: (833) 505-117
www.lghealth.ca

Chief & Council

Decisions
MIFN COVID-19 Emergency By-Law

Press Releases
Video Message

Public Service Announcements

Mushuau Innu First Nation (MIFN)
Mushuau Innu First Nation (MIFN) School
Businesses
Travel

Government of Newfoundland & Labrador

Public Information
Guidance Self-Isolation Plan For Travelers

Government of Newfoundland & Labrador COVID-19 

www.gov.nl.ca/covid-19/

Natuashish COVID-19 Pandemic

Updates
Medicine Wheel - Self Care During COVID 19 Pandemic

Indigenous Services Canada

First Nation Support
Press Releases/Video

Employment & Social Development

Canadian Red Cross

Psychological First Aid
Canadian Red Cross Services & Support in NL
COVID-19 Services Offered by Canadian Red Cross Across Canada
COVID-19 Self-Isolation Support Number

Newfoundland & Labrador Canadian Red Cross

www.redcross.ca/in-your-community/newfoundland-and-labrador